Breast Cancer Female
402
74
105
172
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
27 trials with published results (7%)
Research Maturity
172 completed trials (43% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.2%
17 terminated out of 402 trials
91.0%
+4.5% vs benchmark
8%
33 trials in Phase 3/4
16%
27 of 172 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 172 completed trials
Clinical Trials (402)
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients With rCR and pCR in the Breast After NAST
Nerve Mobilization Techniques After Breast Cancer Surgery
HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer
Preventing Breast Cancer Therapy-related Cardiovascular Toxicity With a Daily-adapted Program With Mhealth Support
Abbreviated MBCT for Depression in Older Black or African American Breast Cancer Survivors
Physical Activity for Adults in the Ontario Breast Screening Program
Evaluation of Safety of Acellular Dermal Matrix(ADM) in Breast Reconstruction
Evaluation of the Clinical Effectiveness and Safety of Acellular Dermal Matrix(SC DERM® Recon) in Breast Reconstruction
Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
SENOVIE France - Therapeutic Mobility and Breast Cancer
The Effect of Psychosocial Support on Improving Breast Cancer Patients Response to Medical Treatment
An Integrated Optimization of Surgery and Radiotherapy Techniques to Improve Cosmetic Outcome and Quality of Life in Breast Conserving Therapy for Breast Cancer Patients (STARLINGS Study)
ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer
ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)
Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial
Conventional Therapy vs. Telerehabilitation With TRAK in Patients Undergoing Axillary Lymph Node Removal
Supporting Health Including Endocrine Treatment for Long Duration
Xenografts Development From Surgical Tumor Samples of Patients With Triple Negative or Luminal B Breast Cancer